CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
56.06
22-11月-24 16:44:58
15 分の遅延
株式
-0.97
-1.70%
本日の幅
55.34 - 57.10
ISIN
N/A
ソース
NASDAQ
-
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
15 11 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
12 11 2024 16:07:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
12 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
11 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
16 10 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
10 10 2024 16:40:28 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
08 10 2024 23:55:11 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08 10 2024 16:01:51 提供 Nasdaq GlobeNewswire
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 9 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 16:40:25 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
12 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 8 2024 16:05:01 提供 Nasdaq GlobeNewswire
-
08 8 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
18 7 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 7 2024 19:29:44 提供 Nasdaq GlobeNewswire
-
18 6 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 6 2024 18:35:30 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >